94 related articles for article (PubMed ID: 2811212)
1. [Treatment of patients with hypertonic disease with plasmapheresis].
Kim IS; Amanchenko VG; Kuznetsov SV; Strizhova NV; Malashenkova IK; Alizade IG
Klin Med (Mosk); 1989 Jul; 67(7):40-3. PubMed ID: 2811212
[TBL] [Abstract][Full Text] [Related]
2. [Effects of plasmapheresis on lymphocytic energy enzymes in hypertension].
Kuznetsov SV; Kim IS; Ananchenko VG
Sov Med; 1990; (5):25-8. PubMed ID: 2389196
[TBL] [Abstract][Full Text] [Related]
3. [Clinico-immunological assessment of the effectiveness of plasmapheresis in the combined therapy of patients with high arterial hypertension].
Legkonogov AV; Kukharchuk VV; Osipov SG; Kutsenko AI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):25-9. PubMed ID: 3606831
[TBL] [Abstract][Full Text] [Related]
4. [The hemodynamic, humoral and cellular effects of plasmapheresis in a refractory form of hypertension].
Koval' SN; Kirienko AN; Vasil'ev IuM; Osetskiĭ AI; Babadzhan VD; Shuliak LN; Zeĭnalov FM
Klin Med (Mosk); 1995; 73(1):25-6. PubMed ID: 7791297
[TBL] [Abstract][Full Text] [Related]
5. [Plasmapheresis in the combined therapy of progressive forms of glomerulonephritis].
Moskaleva ES; Ignatova MS; Korneeva VA; Muromtsev IuV; Tsvetkova EI; Parubinovskaia NM; Kharina EA; Katysheva OV; Krivonos AV
Ter Arkh; 1994; 66(6):42-5. PubMed ID: 7940367
[TBL] [Abstract][Full Text] [Related]
6. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
7. Effect of plasma exchange and thoracic duct drainage on immunological status in glomerulonephritis.
Bonomini V; Vangelista A; Stefoni S; Frascà G; Nanni Costa A
Proc Eur Dial Transplant Assoc; 1981; 18():736-42. PubMed ID: 7330001
[TBL] [Abstract][Full Text] [Related]
8. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis in dermatology].
Potekaev NS; Kurdina MI; Orlov SL; Vorob'ev PA; Gorshkova NN; Barinov VG; Stareev VE
Ter Arkh; 1991; 63(10):133-8. PubMed ID: 1805412
[TBL] [Abstract][Full Text] [Related]
11. [Some mechanisms of pathogenesis of hypertonic type neurocirculatory dystonia in flying personnel].
Denisov SL; Koroleva LV; Lairov IA
Aviakosm Ekolog Med; 1996; 30(1):44-6. PubMed ID: 8963266
[TBL] [Abstract][Full Text] [Related]
12. [Cytochemical parameters of lymphocytes in non-coronarogenic myocardial diseases].
Mazurets AF; Kubyshkin VF
Sov Med; 1991; (3):5-7. PubMed ID: 1882292
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
14. [A correlation of the intensity of the gas discharge luminescence of the skin and the activity of succinate dehydrogenase in blood lymphocytes in different states of the body].
Khunderiakova NV; Volkov AV; Telesheva TIu; Kondrashova MN
Biofizika; 2008; 53(1):123-8. PubMed ID: 18488511
[TBL] [Abstract][Full Text] [Related]
15. [Indices of cellular and humoral immunity in chronic myeloproliferative diseases].
Vygovskaia IaI; Loginskiĭ VE; Mazurok AA; Shnitsar ZV
Ter Arkh; 1986; 58(9):93-6. PubMed ID: 3491438
[TBL] [Abstract][Full Text] [Related]
16. [Blood lymphocytes and mast cells of the detrusor as diagnostic markers of overactive urinary bladder and its immune inflammation].
Pisarev SA
Urologiia; 2009; (3):29-32. PubMed ID: 19670813
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the immunity indices in arteriosclerosis and arterial hypertension].
Brynekova DG
Vrach Delo; 1983 Apr; (4):79-82. PubMed ID: 6603068
[No Abstract] [Full Text] [Related]
18. [The joint use of hemosorption and plasmapheresis in the combined treatment of rheumatoid arthritis patients].
Trusov VV; Bazhenov AN; Stoliarov DD; Odnopozov II
Ter Arkh; 1999; 71(5):22-5. PubMed ID: 10399225
[TBL] [Abstract][Full Text] [Related]
19. [The clinical aspects of using plasmapheresis in sepsis].
Gorshkov MP; Fil'ko VN; Borisenko AP; Evseev NG
Ter Arkh; 1990; 62(9):100-5. PubMed ID: 2281389
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of the effectiveness of plasmapheresis and lymphocytoplasmapheresis in the combined treatment of rheumatoid arthritis].
Mikhaĭlova NA; Mazneva LM; Konovalov GA; Demidova TV; Kulakov GP
Ter Arkh; 1986; 58(8):105-11. PubMed ID: 3764751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
